Objectives: To characterise the phenotypic and genotypic antimicrobial resistance (AMR) profiles and genomic diversity of Prevotella bivia isolates from South African women, and to compare these with publicly available whole genome assemblies.Methods: P. bivia were isolated from lateral vaginal wall swabs and identified using genus-specific primers and 16S rRNA gene sequencing. Phenotypic susceptibility to standard BV antibiotics (metronidazole, clindamycin) and other genitourinary antibiotics was determined by Etest. All isolates underwent Illumina MiSeq whole-genome sequencing to assess genomic diversity and AMR determinant presence, were analysed alongside publicly available assemblies.Results: 35 P. bivia isolates from 30 samples were sequenced. Resistance to metronidazole and clindamycin was low (2.9% and 8.6%), with MIC₉₀ values of 0.6 µg/mL and 0.22 µg/mL, respectively. Resistance to other antibiotics was lower (31-83%), and co-resistance to multiple antibiotic classes was common. Comparative genomic analysis of 33 high-quality genomes revealed low intra-sample diversity overall, although one sample harboured two distinct strains. In one study participant, there was evidence of strain persistence over eight weeks. South African strains showed phylogenetic separation from USA-derived strains. AMR gene determinants were identified, with most strains carrying tetQ (90.9%) and cfxA (72.7%), with the cfxA3/A4 variant associated with amoxicillin MICs. There was rare detection of ermF (3%) and nimK (3%), the latter being the first report of nimK in South Africa, which associated with a previously described Tn6456-like transposon and reduced metronidazole susceptibility.Conclusions: Vaginal P. bivia isolates from South African women exhibited low genomic diversity, with evidence of strain persistence and co-colonisation. Resistance metronidazole remains low, but nimK detection on a transposon highlights potential for AMR gene transfer, underscoring the need for continued monitoring of strain diversity and resistance.